Literature DB >> 100326

Polymorphic acetylation and aminopyrine demethylation in Gilbert's syndrome.

R Platzer, A Küpfer, J Bircher, R Preisig.   

Abstract

Polymorphic acetylation was investigated in twenty-seven patients with Gilbert's syndrome using the sulphadimidine test. Whereas the finding of 51% slow acetylators in seventy-eight control persons agreed well with the expected frequency in a continental European population, the prevalence of slow acetylators in Gilbert's syndrome was increased to 78% (P less than 0.03, Woolf's G-test). After oral administration of 14C-aminopyrine there was no significant difference between seventeen patients with Gilbert's syndrome and twenty-seven normal controls in total plasma clearance of aminopyrine (280 +/- SD 100 and 270 +/- 60 ml/min) and in the disappearance curve of 14CO2 in breath (0.23 +/- 0.04 and 0.22 +/- 0.03 h-1, respectively). Thus, whereas aminopyrine metabolism appears unaffected in the examined patients, the data documents a new association between slow acetylator status and Gilbert's syndrome.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 100326     DOI: 10.1111/j.1365-2362.1978.tb00856.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  10 in total

1.  N-acetylation and debrisoquine hydroxylation polymorphisms in patients with Gilbert's syndrome.

Authors:  W Siegmund; J D Fengler; G Franke; M Zschiesche; O Eike; E Eike; P Meisel; R Wulkow
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

2.  Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.

Authors:  T Zysset; E Peretti
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Thalidomide-induced peripheral neuropathy. A prospective clinical, neurophysiological and pharmacogenetic evaluation.

Authors:  C W Hess; T Hunziker; A Küpfer; H P Ludin
Journal:  J Neurol       Date:  1986-04       Impact factor: 4.849

4.  N-acetylation in healthy and diseased children.

Authors:  E Hadasová; V Brysová; E Kadlcáková
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  N-acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits.

Authors:  M Blum; D M Grant; A Demierre; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 6.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

7.  [Occupational exposure to isocyanates and individual susceptibility].

Authors:  M Berode; H Savolainen
Journal:  Soz Praventivmed       Date:  1993

Review 8.  Gilbert's syndrome and drug metabolism.

Authors:  A F Macklon; R L Savage; M D Rawlins
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

Review 9.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

10.  Antipyrine clearance in patients with Gilbert's syndrome.

Authors:  T Ishizaki; K Chiba; T Sasaki
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.